Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Thorpe

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Journal of Patient-Reported Outcomes|January 10, 2022
Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registryC S Thorpe, T A DeWees, M A Golafshar, et al.
Molecular Phylogenetics and Evolution|March 30, 2001
Intraspecific phylogeography of Lacerta vivipara and the evolution of viviparityY Surget-Groba, B Heulin, C P Guillaume, et al.
Cancer|September 15, 2020
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) studyCarlos E Vargas, Cameron S Thorpe, Amylou C Dueck, et al.
Lasers in Medical Science|June 16, 2012
A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagusJ M Dunn, G D Mackenzie, M R Banks, et al.
Seminars in Oncology|May 18, 2022
Radiation recall dermatitis: A review of the literatureR S Bhangoo, T W Cheng, M M Petersen, et al.
The Breast Journal|April 17, 2020
Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysisCameron S Thorpe, Joshua R Niska, Justin D Anderson, et al.
Advances in Radiation Oncology|March 10, 2023
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003Brady S Laughlin, Cameron S Thorpe, Todd A DeWees, et al.
The Breast Journal|July 25, 2019
Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysisCameron S Thorpe, Joshua R Niska, Marlene E Girardo, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
Efficient discovery of inhibitory ligands for diverse targets from a small combinatorial chemical library of chimeric moleculesD S Thorpe, A W Edith Chan, A Binnie, et al.
Radiation Oncology Journal|October 8, 2021
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapyGabriella F Bulman, Ronik S Bhangoo, Todd A DeWees, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Journal of Patient-Reported Outcomes|January 10, 2022
Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registryC S Thorpe, T A DeWees, M A Golafshar, et al.
Molecular Phylogenetics and Evolution|March 30, 2001
Intraspecific phylogeography of Lacerta vivipara and the evolution of viviparityY Surget-Groba, B Heulin, C P Guillaume, et al.
Cancer|September 15, 2020
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) studyCarlos E Vargas, Cameron S Thorpe, Amylou C Dueck, et al.
Lasers in Medical Science|June 16, 2012
A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagusJ M Dunn, G D Mackenzie, M R Banks, et al.
Seminars in Oncology|May 18, 2022
Radiation recall dermatitis: A review of the literatureR S Bhangoo, T W Cheng, M M Petersen, et al.
The Breast Journal|April 17, 2020
Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysisCameron S Thorpe, Joshua R Niska, Justin D Anderson, et al.
Advances in Radiation Oncology|March 10, 2023
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003Brady S Laughlin, Cameron S Thorpe, Todd A DeWees, et al.
The Breast Journal|July 25, 2019
Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysisCameron S Thorpe, Joshua R Niska, Marlene E Girardo, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
Efficient discovery of inhibitory ligands for diverse targets from a small combinatorial chemical library of chimeric moleculesD S Thorpe, A W Edith Chan, A Binnie, et al.
Radiation Oncology Journal|October 8, 2021
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapyGabriella F Bulman, Ronik S Bhangoo, Todd A DeWees, et al.
Pageof 22